Dr. Carlos Morillo MD, FRCP(C), FACC

Photo of Carlos Morillo
Carlos Morillo Dr.

Current Positions

  • Principal Investigator – Arrhythmia Program and Neglected Diseases Program – Developing Countries, Population Health Research Institute
  • Professor of Medicine – Division of Cardiology, Department of Medicine
  • Director of the Syncope and Autonomic Dysfunction Unit, McMaster University
  • Program Director of the Cardiac Electrophysiology and Autonomic Physiology Fellowship


Dr. Morillo is a Principal Investigator for both the Arrhythmias and Developing Countries research programs at the Population Health Research Institute. Presently, he is a Professor of Medicine, Director of the Syncope and Autonomic Dysfunction Unit, and the Program Director of the Cardiac Electrophysiology and Autonomic Physiology Fellowship. He has held a Heart & Stroke Foundation of Canada Research Fellowship. His main research interests are related with the development of clinical trials in the area of cardiac arrhythmias, syncope and treatment of Chagas Disease. Dr. Morillo has a long-lasting interest in developing new therapeutic approaches for the treatment of atrial fibrillation, autonomic disorders, and Chagas disease. Dr. Morillo has published more than 260 articles in peered reviewed journals; over 320 abstracts and 35 book chapters in well know Cardiology textbooks. He is also the recipient of many prestigious awards including the Charles Pfizer Research Award, the National Academy of Medicine – Aventis Clinical Research Award as well as the Award for Best Researcher from the Sociedad Colombiana de Cardiologia and was selected as one of the 10 most influential Hispanic-Canadians in 2010.

Research Interests

  • Sympathetic Microneurography
  • Baroreflex modulation
  • Heart rate and blood pressure variability
  • Linear and non-linear dynamics of biological signals
  • Plethysmography
  • Lower body negative pressure
  • Tilt table testing
  • Benznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT)
  • A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267) (STOP CHAGAS)
  • First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT -2 Study)

Publications are listed in chronological order by descending date. Link takes user to pubMed for publication details.